pubrio
Parse Biosciences logo

Parse Biosciences

Privately Held
研究行业200+ employeesFounded 2018🇺🇸 美国
总部
🇺🇸700 Dexter Ave N, Suite 600, Seattle, Washington 98109, US (+2)
行业
研究行业
员工人数
200+
成立年份
2018
公司类型
Privately Held
排名
#3,169,246

Parse Biosciences is a biotechnology company based in Seattle, founded in 2018. The company focuses on advancing single-cell genomics with innovative solutions that allow researchers to analyze complex biological systems efficiently. Their mission is to support breakthroughs in various fields, including developmental biology, immunotherapy, neurology, diabetes, vascular disease, and cancer. The company specializes in single-cell sequencing technologies, particularly through their Evercode™ Platform. This platform provides an end-to-end solution for library preparation, sequencing, and data analysis, enabling whole transcriptome sequencing and immune profiling without the need for custom instruments. Their offerings include Evercode™ Whole Transcriptome Kits and Immune Profiling Kits, which facilitate scalable workflows and detailed immune repertoire analysis. Parse Biosciences serves researchers and institutions in academic, clinical, and pharmaceutical settings, providing tools that enhance the study of cellular heterogeneity and disease mechanisms.

专长
研究行业生物技术医疗保健
5 / 6
活跃市场
United Kingdom · Germany · France
1
新市场
Russia
762
信号
最近 90 天
-48%
势头
较上一周期
扩张评分早期
12 / 100

全球扩张

实时
United KingdomGermanyFrance
最多 3 个市场
最近 90 天
阶段
探索中6投入中0拓展中0规模化中0
近期动态
推进中30天
新增90天
+3个市场已锁定
已显示 6 个中的 3 个

解锁市场时间线与信号动态

活动脉搏

新增 招聘 活动 — 刚出现 2 个新信号。

最近 90 天
招聘
2新增
招聘
营销与公关
760-29%
广告投放
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇬🇧United Kingdom进入的第 1st 个市场 · 2024
探索中
102 个信号
2
🇩🇪Germany进入的第 2nd 个市场 · 2024
探索中
101 个信号
3
🇫🇷France进入的第 3rd 个市场 · 2024
探索中
100 个信号
+3个市场已锁定
已显示 6 个中的 3 个
当前阶段探索中试探市场
置信度48%
开始追踪于2024首个信号

近期信号

广告投放🇬🇧 United Kingdom今天

If you're doing single cell in 2026, you need to be in this room. Join us in London, January 27, for the Parse Biosciences user group meeting, featuring:🗣️ Customer talks on real-world applications📰 Latest Parse updates💬 Open discussion to swap approaches and best practices🤝 Networking with fellow single cell researchersRegister now: https://lnkd.in/dvr7CCMK ...

广告投放🇯🇵 Japan昨天

[On-Demand Webinar] Why Single Cell RNA Sequencing?

注册以查看完整信号动态

了解一下

关于 Parse Biosciences 的常见问题

关于 Parse Biosciences 的业务、市场和增长信号的快速解答。

Parse Biosciences is a biotechnology company based in Seattle, founded in 2018. The company focuses on advancing single-cell genomics with innovative solutions that allow researchers to analyze complex biological systems efficiently. Their mission is to support breakthroughs in various fields, including developmental biology, immunotherapy, neurology, diabetes, vascular disease, and cancer. The company specializes in single-cell sequencing technologies, particularly through their Evercode™ Platform. This platform provides an end-to-end solution for library preparation, sequencing, and data analysis, enabling whole transcriptome sequencing and immune profiling without the need for custom instruments. Their offerings include Evercode™ Whole Transcriptome Kits and Immune Profiling Kits, which facilitate scalable workflows and detailed immune repertoire analysis. Parse Biosciences serves researchers and institutions in academic, clinical, and pharmaceutical settings, providing tools that enhance the study of cellular heterogeneity and disease mechanisms.

800M+
监测企业
50+
本地数据来源
16
动向信号
每日
更新频率
“企业进入市场的那一周,我们就触达他们——而不是一个季度之后。”
增长负责人 · Pubrio 上一支 500+ 人的营收团队

洞察全球企业的每一步动向。

与我们的团队预约一次动向地图导览。

pubrio

Pubrio 把横跨 200+ 个市场的扩张信号整合为一张实时图谱,让营收团队看见哪些公司正进军新市场,并把握时机。

关注

向 AI 了解 Pubrio

© 2026 Pubrio。保留所有权利。